Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Winter Reminders from WFD
UPDATE: Charges Are Laid After Two Fires in the City
SWPH Reports High Influenza Risk
Deputy Warden Appointed for 2026
Handbags for Hospice to Shimmer for Sakura House
Beachville Museum Employee Receives Award
SWPH Issues Cold Weather Alert
Oxford OPP Briefs - Dec. 15th 2025
White Christmas Not Guaranteed for Oxford
PJHL Recap - Dec 12th to Dec 14th
Holiday Safety Tips from OCAR
Paris Man Charged with Impaired
Rob Reiner Dead at 78
Christmas Lights Stolen in Ingersoll
UPDATE: Cyber Security Experts Investigating Oxford Incident
PJHL Preview - Dec. 12th to Dec. 14th
Tour of Lights Begins this Weekend
Drunk Drivers Charged in Woodstock
Week Three Results for Festive RIDE Campaign
Woodstock Passes 2026 Capital Budget
Comments
Add a comment